NCT02008045

Brief Summary

The purpose of this study is to collect and compare information from cranial ultrasounds, magnetic resonance imaging scans, neurological exam and neuropsychological assessments of children. The investigators hope that the information collected in this study will help with early screening, diagnosis and treatment of brain injury in newborns as well as identify a connection between MR imaging (MRI-magnetic resonance imaging, MRS-magnetic resonance spectroscopy) and neurodevelopmental outcome.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
557

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2013

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 11, 2013

Completed
11.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 2, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 2, 2025

Completed
Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

15.9 years

First QC Date

November 15, 2013

Last Update Submit

January 12, 2026

Conditions

Keywords

MRIImagingNeurocognitiveWhite matter injury

Outcome Measures

Primary Outcomes (1)

  • Developmental Assessment

    Administration of neurodevelopmental testing and completion of parent questionnaires regarding the child's development.

    18 Months

Secondary Outcomes (2)

  • Assessment of White Matter Injury in Brain

    Baseline

  • Changes in White Matter Injury from Baseline

    at 6 Years

Study Arms (2)

Neonates at Risk for Brian Injury

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

Device: Magnetic Resonance ImagingBehavioral: Neurodevelopmental Testing

Term Neonates

Magnetic Resonance Imaging Neurodevelopmental Testing - 18 Month

Device: Magnetic Resonance ImagingBehavioral: Neurodevelopmental Testing

Interventions

Brain MRI without Contrast

Neonates at Risk for Brian InjuryTerm Neonates

Validated battery of neurodevelopmental and psychological tests.

Neonates at Risk for Brian InjuryTerm Neonates

Eligibility Criteria

Age1 Day - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Participants will be enrolled between birth and 7 years of age.

You may qualify if:

  • Preterm babies and neonates with congenital heart disease
  • Term Neonates

You may not qualify if:

  • Severe congenital brain malformation
  • Significant chromosomal abnormality / syndrome which could confound the neurodevelopmental follow up data
  • Preterm birth and congenital heart disease
  • Focal neurological abnormality
  • Chronic seizures
  • Severe congenital brain malformation
  • Significant chromosomal abnormality/ syndrome which could confound the neurodevelopmental follow up data
  • Major pregnancy complication (diabetes, eclampsia)
  • Sepsis
  • ECMO
  • Significant birth trauma and/or hypoxic ischemic injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, 15224, United States

Location

MeSH Terms

Interventions

Magnetic Resonance Imaging

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Ashok Panigrahy, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 15, 2013

First Posted

December 11, 2013

Study Start

July 1, 2009

Primary Completion

June 2, 2025

Study Completion

June 2, 2025

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Materials generated under the project will be disseminated in accordance with the University of Pittsburgh and NIH policies. Depending on such policies, materials may be transferred to others under the terms of a material transfer agreement. Publication of data shall occur during the project, if appropriate, or at the end of the project, consistent with normal scientific practices. Research data which documents, supports and validates research findings will be made available after the main findings from the final research data set have been accepted for publication. Such research data will be redacted to prevent the disclosure of personal identifiers.

Time Frame
De-identified data will be shared once all study subjects have completed participation and data analysis has been completed.
Access Criteria
De-identified data will be shared via secure website with access granted by PI research team.

Locations